Obesity, and in particular the accumulation of abdominal visceral fat, as well as type 2 diabetes mellitus, coronary disease, and arterial hypertension are accompanied by a reduction of serum adiponectin (Arita et al., 1999; Lara-Castro et al., 2007). Here, ADIPOQ is linked to obesity disorder.